Drug – bio-affecting and body treating compositions – Whole live micro-organism – cell – or virus containing – Animal or plant cell
Reexamination Certificate
2005-03-15
2005-03-15
Kemmerer, Elizabeth (Department: 1647)
Drug, bio-affecting and body treating compositions
Whole live micro-organism, cell, or virus containing
Animal or plant cell
C424S093100, C435S325000, C530S300000, C530S350000, C530S387100, C530S399000
Reexamination Certificate
active
06866843
ABSTRACT:
Methods and compositions are described for the treatment of type I insulin-dependent diabetes mellitus and other conditions using newly identified stem cells that are capable of differentiation into a variety of pancreatic islet cells, including insulin-producing beta cells, as well as hepatocytes. Nestin has been identified as a molecular marker for pancreatic stem cells, while cytokeratin-19 serves as a marker for a distinct class of islet ductal cells. Methods are described whereby nestin-positive stem cells can be isolated from pancreatic islets and cultured to obtain further stem cells or pseudo-islet like structures. Methods for ex vivo differentiation of the pancreatic stem cells are disclosed. Methods are described whereby pancreatic stem cells can be isolated, expanded, and transplanted into a patient in need thereof, either allogeneically, isogeneically or xenogenically, to provide replacement for lost or damaged insulin-secreting cells or other cells.
REFERENCES:
patent: 6001647 (1999-12-01), Peck et al.
patent: 6090400 (2000-07-01), Elliott
patent: 6146653 (2000-11-01), Elliott
patent: 6326201 (2001-12-01), Fung et al.
patent: 6372493 (2002-04-01), Brothers
patent: 6436704 (2002-08-01), Roberts et al.
patent: 20010049827 (2001-12-01), Hunter et al.
patent: 9715310 (1997-05-01), None
patent: 0139784 (2001-06-01), None
Schumacher et al. Transplantation of embryonic porcine mesencephalic tissue in patients with PD.□□Neurology. 54(5):1042-1050, 2000.*
Reemtsma et al. Renal heretotransplantation in man. Ann Surg. 160:384-410, 1964.*
Starzl et l.l Baboon-to-human liver transplantation. Lancet. 341(8837):65-71, 1993.*
Greiner et al. SCID mouse models of human stem cell engraftment. Stem Cells. 16(3):166-177, 1998.*
Soria et al. From stem cells to beta cells: new strategies in cell therapy of diabetes mellitus. Diabetologia. 44(4):407-415, 200.*
Szukudelski, T. The mechanism of alloxan and streptozotocin action in B cells of the rat pancreas. Physiol Res. 50(6):537-54 2001.*
Yoon et al. Cellular and molecular pathogenic mechanisms of insulin-dependent diabetes mellitus. Ann N Y Acad Sci. 928:20 211, 2001.*
van der Loo et al. Nonobese diabetic/severe combined immunodeficiency (NOD/SCID) mouse as a model system to study the engraftment and mobilization of human peripheral blood stem cells. Blood. 92(7):2556-2570, 1998.*
Huang et al. Phenotypic determination and characterization of nestin-positive precursors derived from human fetal pancreas. Lab Invest. 83(4):539-547, 2003.*
Wu et al. “Human fetal pancreas nestin positive cells correct hyperglycemia in mice”. from meeting “Pancreatic Development, proliferation, and stem cells”, Oct. 18-19, 2001, Bethesda, MD.*
Wu et al. “Human fetal pancreas-derived nestin positive stem cells from long term cultures correct hyperglycemia when implanted into diabetic mice” U.C. Davis/VSTP Retreat, Aug. 26, 2002.*
Atkinson et al. The NOD mouse model of type 1 diabetes: as good as it gets? Nat Med. 5(6):601-604, 1999.*
Janeway and Travers. Immunobiology. London: Current Biolopgy Limited, 1997. p. 2:46.*
Edlund, H. Pancreatic organogenesis—developmental mecahnisms and implications for therapy. Nature Rev Genet 3: 524-532, 2002.*
Zulewski et al. Multipotential nestin-positive stem cells isolated from adult pancreatic islets differentiate ex vivo into pancreatic endocrine, exocrine, and hepatic phenotypes. Diabetes 50: 521-533, 2001.*
Lumelsky et al. Differentiation of embryonic stem cells to insulin-secreting structures similar to pancreatic islets. Science 292: 1389-1394, 2001.*
Bonner-Weir S et al. Pancreatic stem cells. J Pathol. 197(4):519-26, 2002.*
Efrat, S. Prospects for treatment of type 2 diabetes by exapnsion of the B-cell mass. Diabetes 50(Supp1): S189-S190, 2001.*
Yamaoka, T. Regeneration therapy of pancreatic B cells: towards a cure for diabetes? Biochem Biophys Res Comm 296: 1039-1043, 2002.*
Beattie et al., 1994, Acid β-Galactosidase:A Developmentally Regulated Marker of Endocrine Cell Precursors in the Human Fetal Pancreas, Journ. Clin. Endo. and Metab. 78:5, 1232-1240.
Bouwens, L. 1998.Transdifferentiation versus stem cell hypothesis for the regeneration of islet beta cells in the pancreas, Microsc. Res. Tech. 43:332-336.
Cornelius et al., 1997,In Vitro-Generation of Islets in Long Term Cultures of Pluripotent Stem Cells From Adult Mouse PancreasHorm. Metab. Research 29 1997 271-277.
Ferber et al., 2000,Pancreatic and Duodenal Homeobox Gene 1 induces Expresssion of Insulin Genes in Liver and Ameliorates Streptozocin-induced Hyperglycemia, Nature Med., 6:568-572).
Hunziker and Stein, 2000,Nestin-Expressing Cells in the Pancreatic Islets of Langerhans, biochem and Biophys. Research Commun, 271, 116-119.
Lendahl, U., et al. 1990.CNS stem cells express a new class of intermediate filament protein. Cell 60:585-595.
Ramiya et al., 2000,Reversal odf Insulin-dependent Diabetes Using Islets Generated in vitro from Pancreatic Stem Cells, Nature Med., 6:278-282.
Stoffers et al., 2000,Insulinotropic Glucagon-Like Peptide 1 Agonists Stimulate Expression of Homeodomain Protein IDX-1 and Increase Islet Size in Mouse Pancreas, Diabetes, 49:741-748.
Xu et al., 1999,Extendin-4 Stimulates Both β-Cell Replication and Neogenesis, Resulting in Increased β-Cell Mass and Improved Glucose Tolerance in Diabetic Rats, Diabetes, 48:2270-2276.
Yasumizu et al., 1987,Treatment of Type 1 Diabetes Mellitus in Non-Obese Diabetic Mice by Transplantation of Allogeneic Bone Marrow and Pancreatic Tissue, PNAS 84:6555-6557.
Peck, et al., Pancreatic stem cells: building blocks for a better surrogate islet to treat type 1 diabetes, 2001,Ann Med. 33: 186-192.
Zhou, et al. The ABC transporter Bcrp1/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotype, 2001,Nature Medicinevol. 7, No. 9: 1028-1034.
Abraham Elizabeth
Faustman Denise L.
Habener Joel F.
Thomas Melissa K.
Vallejo Mario
Bunner Bridget E.
Kemmerer Elizabeth
Palmer & Dodge LLP
Spar Elizabeth N.
Viacell, Inc.
LandOfFree
Method of transplanting in a mammal and treating diabetes... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of transplanting in a mammal and treating diabetes..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of transplanting in a mammal and treating diabetes... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3371750